Download PDF
CC BY 4.0 · Journal of Diabetes and Endocrine Practice
DOI: 10.1055/s-0045-1804498
Case Report

A Delayed Post-COVID-19 Silent Thyroiditis

Farah Alkhuboli
1   Department of Anaesthesiology, Al Qassimi Hospital, Emirates Health Services, Sharjah, United Arab Emirates
,
Farah Soukieh
2   Department of Internal Medicine, Al Qassimi Hospital, Sharjah, Emirates Health Services, Sharjah, United Arab Emirates
,
Ahmad Subhi 
3   Department of Internal Medicine, Adult Infectious Diseases, Al-Qassimi Hospital, Emirates Health Services, Sharjah, United Arab Emirates
,
Hussam Abusahmin
4   Department of Endocrinology, Al Qassimi Hospital, Emirates Health Services, Sharjah, United Arab Emirates
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Although respiratory symptoms are the predominant manifestations of coronavirus disease 2019 (COVID-19) infection, thyroid dysfunction is a commonly recognized sequela. We report a case of delayed silent thyroiditis that manifested 3 months following COVID-19 infection in a 14-year-old female.

Case Description A 14-year-old female presented with palpitations, tremors, and sweating that started around 3 months after the resolution of COVID-19 infection.

Her presentation, thyroid function tests, along with ultrasonographic pictures and radioiodine uptake scan of the thyroid were consistent with a diagnosis of silent thyroiditis. She was managed symptomatically with propranolol, after which her symptoms improved, and thyroid function tests returned to normal.

Conclusion COVID-19 is a possible trigger for delayed silent thyroiditis that health care providers should recognize for accurate diagnosis and management.

Keywords

COVID-19 infection - thyroiditis - case report

Authors' Contribution

All the authors contributed to the drafting and revising of the manuscript and approved its final version.


Confirmation of Consent for Publications

The authors confirm that they have obtained the consent of the patient's guardian for publication of the case report on a totally anonymous basis.


Compliance with Ethical Principles

Approval of the institutional review board is not required for single case reports or small case series provided patients give consent and reporting is completely anonymous.




Publication History

Article published online:
09 April 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Li L, Qin L, Xu Z. et al. Using artificial intelligence to detect COVID-19 and community-acquired pneumonia based on pulmonary CT: evaluation of the diagnostic accuracy. Radiology 2020; 296 (02) E65-E71
    CrossrefPubMedSearch in Google Scholar
  • 2 Lodigiani C, Iapichino G, Carenzo L. et al; Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9-14
    CrossrefPubMedSearch in Google Scholar
  • 3 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
    CrossrefPubMedSearch in Google Scholar
  • 4 Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine 2020; 68 (03) 471-474
    CrossrefPubMedSearch in Google Scholar
  • 5 Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020; 18 (09) 2128-2130.e2
    CrossrefPubMedSearch in Google Scholar
  • 6 Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9 (01) 45
    CrossrefPubMedSearch in Google Scholar
  • 7 Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M. COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review. Front Endocrinol (Lausanne) 2021; 12: 707726
    PubMedSearch in Google Scholar
  • 8 Walker P. Silent thyroiditis. Can Fam Physician 1984; 30: 1337-1339
    PubMedSearch in Google Scholar
  • 9 Quaytman J, Gollamudi U, Bass N, Suresh S. Reactive arthritis and silent thyroiditis following SARS-CoV-2 infection: case report and review of the literature. Clin Case Rep 2022; 10 (02) e05430
    PubMedSearch in Google Scholar
  • 10 Capezzone M, Tosti-Balducci M, Morabito EM. et al. Silent thyroiditis following vaccination against COVID-19: report of two cases. J Endocrinol Invest 2022; 45 (05) 1079-1083
    PubMedSearch in Google Scholar
  • 11 Bornemann C, Woyk K, Bouter C. Two cases of subacute thyroiditis following SARS-COV-2 vaccination. Front Med (Lausanne) 2021; 8: 737142
    PubMedSearch in Google Scholar
  • 12 Furuta Y, Masuoka T, Narishige R, Tateno A. Delayed diagnosis of painless thyroiditis in an adolescent presenting with aggression and disruptive behavior initially attributed to worsening of a psychiatric disorder. J Nippon Med Sch 2024; ;•••:
    CrossrefPubMedSearch in Google Scholar